Lennart Mulder

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers

Esther H. Lips, Lennart Mulder, Anne M.M. Oonk et al. · British Journal of Cancer · 2013 · 241 citations · Full text

Medicine, Genetics, Oncology +16

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer

Petra ter Brugge, Petra Kristel, Eline van der Burg et al. · JNCI Journal of the National Cancer Institute · 2016 · 208 citations

Medicine, Oncology, Pharmacology +16

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

Jorma J. de Ronde, Juliane Hannemann, Hans Halfwerk et al. · Breast Cancer Research and Treatment · 2009 · 169 citations · Full text

Medicine, Oncology, Surgery +13

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response

Esther H. Lips, Lennart Mulder, Jorma J. de Ronde et al. · Breast Cancer Research and Treatment · 2013 · 116 citations · Full text

Medicine, Oncology, Breast Oncology +13

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

Esther H. Lips, Tapsi Kumar, Anargyros Megalios et al. · Nature Genetics · 2022 · 92 citations · Full text

Medicine, Molecular Genetics, Oncology +17